Antibody Engineering & Therapeutics is part of the Informa Connect Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Jennifer Cochran is the Shriram Chair and Professor of Bioengineering, and (by courtesy) of Chemical Engineering at Stanford University. Her research interests include protein-based drug discovery and development for applications in oncology and regenerative medicine. She is passionate about translating basic science discoveries from bench to beside; several of the designer proteins created in her lab are at various stages of commercialization and clinical translation. While on leave from Stanford from 2015-2017, Dr. Cochran co-founded and served in the role of Chief Scientific Officer at Lagunita Biosciences, a healthcare investment company and incubator that creates and grows early stage companies to commercialize impactful translational science. During this time, she co-founded several biotech companies, including xCella Biosciences and Nodus Therapeutics, and has served in various executive roles in these organizations.